|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 239/95 | (2006.01) |
| A61K 31/517 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 3759083 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19708817.2 |
| Date of filing the European patent application | 2019-02-28 | |
| (97) | Date of publication of the European application | 2021-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-04 |
| (46) | Date of publication of the claims translation | 2022-07-11 |
| (86) | Number | PCT/EP2019/054941 |
| Date | 2019-02-28 |
| (87) | Number | WO 2019/166532 |
| Date | 2019-09-06 |
| (30) | Number | Date | Country code |
| 18159583 | 2018-03-01 | EP |
| (72) |
MC GOWAN, David, Craig , BE
EMBRECHTS, Werner, Constant, Johan , BE
GUILLEMONT, Jérôme, Émile, Georges , FR
COOYMANS, Ludwig, Paul , BE
JONCKERS, Tim, Hugo, Maria , BE
RABOISSON, Pierre, Jean-Marie, Bernard , BE
|
| (73) |
Janssen Sciences Ireland Unlimited Company ,
Barnahely, Ringaskiddy, Co Cork,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2,4-Diaminochinazolino dariniai ir jų naudojimas virusinės infekcijos, vėžio ir alergijų gydymui |
| 2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIES |
| Payment date | Validity (years) | Amount | |
| 2024-01-30 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-02-28 |